Phase IIIb, Randomized, Triple-blinded and Crossover Study to Evaluate the Effect of Magnesium Pantoprazole 20mg Bid Versus Magnesium Pantoprazole 40mg qd on Intragastric Acid Inhibition Assessed by pHmetry, in Healthy Volunteers

Trial Profile

Phase IIIb, Randomized, Triple-blinded and Crossover Study to Evaluate the Effect of Magnesium Pantoprazole 20mg Bid Versus Magnesium Pantoprazole 40mg qd on Intragastric Acid Inhibition Assessed by pHmetry, in Healthy Volunteers

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 08 Aug 2013

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Duodenal ulcer; Erosive oesophagitis; Gastritis; Gastro-oesophageal reflux; Heartburn; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacodynamics
  • Sponsors Takeda
  • Most Recent Events

    • 31 Aug 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 30 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top